USPTO serial 88193779
ABIDE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SHANOSKI, JOANNA MARIE
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ABIDE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
LUNDBECK LA JOLLA RESEARCH CENTER, INC.
DEERFIELD, IL
Other trademarks owned by LUNDBECK LA JOLLA RESEARCH CENTER, INC.
Valby, DK
San Diego, CA
San Diego, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alexander Reid
Alexander Reid White & Case LLP1221 Avenue of the AmericasTrademark DepartmentNew York, NY 10020Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Medical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of treating diseases involving lipid signaling pathways; research and development in pharmacology for the purpose of treating diseases involving the signaling pathways of the central nervous system; medical research for use in treating central nervous system disorders; pharmaceutical research for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; pharmaceutical research in the field of enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases; pharmaceutical research in the fields of immunology, namely, rheumatology, oncology, namely, immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology, namely, fertility, infectiology, namely, virology, ophthalmology, hepatology, neurology, geriatrics, laboratory medicine, clinical diagnostics, genetics and phenomics, pathology and forensics, proteomics, veterinary medicine and diagnostics, and pharmaceutical research tool development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research using enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases for use in drug development; pharmaceutical research, namely, research relating to enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases for improving pharmacological properties; pharmaceutical research, namely, research relating to enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases for use in connection with a wide variety of therapeutic areas | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LUNDBECK LA JOLLA RESEARCH CENTER, INC.
- Other trademarks owned by H. LUNDBECK A/S
- Other trademarks owned by Abide Therapeutics, Inc.
- Other trademarks owned by Abide Therapeutics, Inc.
- Other trademarks in Class 042
- Similar marks named ABIDE
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 1, 2022 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 1, 2022 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 4, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 3, 2021 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Dec 3, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 23, 2021 | EXT5 | SOU EXTENSION 5 FILED | — |
| Nov 23, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 16, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 16, 2021 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Nov 16, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 16, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 28, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 26, 2021 | EX4G | SOU EXTENSION 4 GRANTED | — |
| May 26, 2021 | EXT4 | SOU EXTENSION 4 FILED | — |
| May 26, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 8, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 4, 2020 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Dec 4, 2020 | EXT3 | SOU EXTENSION 3 FILED | — |
| Dec 4, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 11, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 9, 2020 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jun 9, 2020 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jun 9, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 8, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 8, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 8, 2020 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jun 8, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 8, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 8, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 29, 2020 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Dec 19, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 17, 2019 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 17, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 17, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 9, 2019 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jun 25, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 30, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 30, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 10, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 22, 2019 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 22, 2019 | ALIE | ASSIGNED TO LIE | — |
| Feb 27, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 27, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 27, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 27, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 27, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 19, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 11, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 17, 2018 | NWAP | NEW APPLICATION ENTERED | — |